Cell And Gene Therapy Market - By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $4000 | Pages : 282 | Published : May 2021 | SKU CODE : o&s245 | Format :

Request Sample

Cell And Gene Therapy Market Definition

The cell and gene therapy market consists of sales of cell and gene therapies by entities that produce them. Cell and gene therapy work with similar therapeutic goals, targeting DNA or RNA inside or outside the body. These therapies modify genetic material to improve functioning or fight diseases.

Genes are the basic physical and functional unit of heredity, received from one’s parents. Genes act as a code for the creation of all proteins in a living organism. Gene therapy seeks to manipulate a patient’s cells to alter the biological property of cells for the treatment of an inherited or acquired disease. It works by several mechanisms, including replacing a disease-causing gene with a healthy copy of the gene, inactivating an ill-functioning disease-causing gene, or introducing a modified gene into the body to treat diseases.

Cell And Gene Therapy Market Size

The global cell and gene therapy market reached a value of nearly $4,390.3 million in 2020, having increased at a compound annual growth rate (CAGR) of 25.5% since 2015. The market is expected to grow from $4,390.3 million in 2020 to $15,482.3 million in 2025 at a rate of 28.7%. The market is then expected to grow at a CAGR of 17.3% from 2025 and reach $34,317.9 million in 2030.  

Growth in the historic period in the cell and gene therapy market resulted from increase in investments in cell and gene therapies, growth in research and development, advances in cancer drug discovery, rise in public-private partnerships, strong economic growth in emerging markets, increased healthcare expenditure, and rising in pharmaceutical R&D expenditure. The market was restrained by inadequate reimbursements, challenges due to regulatory changes, low healthcare access, and limited number of treatment centers.

Going forward increasing prevalence of cancer and chronic diseases, rising geriatric population, rising geriatric population, rising focus on cell and gene therapy, and rise in healthcare expenditure will drive the growth in the cell and gene therapy market. Factors that could hinder the growth of the market in the future include high costs of therapy, stringent regulations, reimbursement challenges, and coronavirus pandemic.

Cell And Gene Therapy Market Drivers

The key drivers of the cell and gene therapy market include:

Increasing Prevalence of Cancer And Chronic Diseases  

The rising prevalence of cancer and chronic cases across the globe is likely to contribute to the growth of the cell and gene therapy market during the forecast period. According to the Union for International Cancer Control (UICC)’s GLOBOCAN 2020: New Global Cancer Data published in December 2020, the global cancer burden has risen to 19.3 million cases and 10 million cancer deaths in 2020. Furthermore, according to the International Agency for Research on Cancer (IARC), globally 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease. As suggested by the new estimates, more than 50 million people are living within five years of a past cancer diagnosis. Socio-economic risk factors and the elderly population are a major cause for increasing cancer and chronic diseases, thereby driving the growth of the cell and gene therapy market.

Cell And Gene Therapy Market Restraints

 

The key restraints on the cell and gene therapy market include:

Stringent Regulations

Stringent regulations imposed by regulators related to safety, efficacy, and quality are projected to act as a major challenge for players operating in the cell and gene therapy market. All medicines and treatments go through stringent testing in the lab (pre-clinical research) and in small groups of patients (clinical research). The European Medicines Agency (EMA) and The United States Food and Drug Administration (FDA) are the two main bodies regulating these novel therapies while getting them to market. The legislation on cell therapy in Europe is based on three directives Directive 2003/63/EC (which defines cell therapy products as clinical products and includes their specific requirements), Directive 2001/20/EC (which emphasizes that CTs are mandatory for such cell therapy products and describes the special requirements for approval of such trials),   Directive 2004/23/EC (which establishes the standard quality, donation safety, harvesting, tests, processing, preservation, storage, and distribution of human tissues and cells). The adverse events and patients’ deaths seen with therapies such as CAR-T cells in the early stages of their development are restricting these regulators from approvals of cell and gene therapies.

Cell And Gene Therapy Market Trends

Major trends influencing the cell and gene therapy market include:

Chimeric Antigen Receptor (CAR) T-Cell Therapy

Chimeric antigen receptor (CAR) T-cell therapy is increasingly gaining traction. In (CAR) T -cell therapy, T cells are collected from the patient’s blood and are genetically engineered to produce modified receptors at their surface, known as chimeric antigen receptors (CARs). These modified T cells with special structures (receptors) are then reinfused into the patient. These modified receptors of T cell help in targeting the surface antigen of the cancer cell t and in turn result in the killing of tumor cells in patients. In 2020, the US-FDA approved Bristol-Myers Squibb`s two CAR-T cell therapies to treat lymphoma and multiple myeloma.  FDA approved CAR-T cells therapy treatments like Tisagenlecleucel for the treatment of B-cell precursor acute lymphoblastic leukemia (ALL) in children and Axicabtagene ciloleucel for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

Global Research Initiatives And Funding

Pharmaceutical companies and federal governments are increasingly working together in partnerships and collaborations to provide funding and implement incentive programs for the research and development (R&D) of cell and gene therapies. These partnerships provide financial and technical assistance across different clinical development phases to pharmaceutical companies. For instance, in June 2020, CSL Behring, a biotechnology company, and Seattle Children's Research Institute announced a strategic alliance to develop advanced stem cell gene therapy treatments for primary immunodeficiency diseases. In October 2019, the National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation pledge to invest $200 million over the next four years to speed the development of affordable gene therapies for human immunodeficiency virus (HIV) and sickle cell disease (SCD) on a global scale.

Opportunities And Recommendations In The Cell And Gene Therapy Market

Opportunities –The top opportunities in the cell and gene therapy market segmented by product will arise in the gene therapy segment, which will gain $8,977.0 million of global annual sales by 2025. The top opportunities in the cell and gene therapy market segmented by application will arise in the oncology segment, which will gain $6,730.2 million of global annual sales by 2025. The cell and gene therapy market size will gain the most in the USA at $3,360.9 million.

Recommendations –To take advantage of these opportunities, The Business Research Company recommends the cell and gene therapy companies to consider investing in the development of advanced therapies such as chimeric antigen receptor (CAR) T-cell therapy to offer patients with better treatment options, work on strategic alliances collaborations to integrate advanced technologies in the manufacturing of cell and gene therapy, expanding activities to emerging markets to gain market share, offer skimmed pricing to attract the users, leverage e-commerce tools to reach targeted people, among other strategies.

USA; China; Japan; Germany; France; UK; Russia; India; Brazil; Australia; South Korea; Indonesia; Others

Cell And Gene Therapy Market Segmentation

The cell and gene therapy market is segmented by product, by application and by geography.
By Product-
The cell and gene therapy market is segmented by product into
    • a) Cell Therapy
    • b) Gene Therapy
The gene therapy market was the largest segment of the cell and gene therapy market segmented by product, accounting for 72.4% of the total in 2020. Going forward, the gene therapy segment is expected to be the fastest growing segment in the cell and gene therapy market segmented by product, at a CAGR of 30.8% during 2020-2025.
By Application -
The cell and gene therapy market is segmented by application into
    • a) Oncology
    • b) Neurological Disorders
    • c) Others
The oncology market was the largest segment of the cell and gene therapy market segmented by application, accounting for 64.6% of the total in 2020. Going forward, the neurological disorders segment is expected to be the fastest growing segment in the cell and gene therapy market segmented by application, at a CAGR of 30.7% during 2020-2025.
By Geography-The cell and gene therapy market is segmented by geography into
    o North America
    • • USA
    o Western Europe
    • • UK
    • • Germany
    • • France
    o Asia Pacific
    • • China
    • • India
    • • Japan
    • • Australia
    • • Indonesia
    • • South Korea
    o Eastern Europe
    • • Russia
    o South America
    • • Brazil
    o Middle East
    o Africa
North America was the largest region in the global cell and gene therapy market, accounting for 49.8% of the total in 2020. It was followed by the Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the cell and gene therapy market will be the Middle East and South America where growth will be at CAGRs of 60.5% and 59.9% respectively. These will be followed by Asia Pacific and Eastern Europe, where the markets are expected to register CAGRs of 49.4% and 38.9% respectively.

Cell And Gene Therapy Competitive Landscape

Major Competitors are:

  • • Biogen Inc.
  • • Novartis AG
  • • Gilead Sciences
  • • Ionis Pharmaceuticals, Inc.
  • • Alnylam Pharmaceuticals, Inc.

Other Competitors Include:

  • • ArrowHead Pharmaceuticals Inc.
  • • Spark Therapeutics
  • • Bluebird Bio, Inc.
  • • RegenexBio
  • • Mesoblast Limited
  • • Biocon
  • • Cipla
  • • Stempeutics Research Pvt. Ltd.
  • • EdiGene, Inc.
  • • Immunochina
  • • Takara Bio
  • • Daiichi Sankyo Company
  • • Ultragenyx Pharmaceutical Inc
  • • Mitsubishi Tanabe Pharma
  • • Oxford Biomedica plc
  • • Santen Pharmaceutical Co.
  • • Therapeutic Innovation Australia
  • • Merck
  • • GenScript
  • • Cellular Biomedicine Group
  • • GE Healthcare
  • • inStem
  • • Lonza
  • • Nikon CeLL innovation Co. Ltd.
  • • Bristol-Myers Squibb
  • • Amgen
  • • Pfizer
  • • Albumedix Ltd
  • • Kite Pharma
  • • Catalent
  • • Oxford BioTherapeutics
  • • Freeline Therapeutics
  • • Avectas
  • • DiNAQOR AG
  • • Vivet Therapeutics
  • • Allergan
  • • Takeda Pharmaceutical
  • • PsiOxus Therapeutics
  • • Herantis Pharma Plc
  • • Biocad
  • • Celgene Corporation
  • • Johnson & Johnson
  • • F. Hoffmann-La Roche Ltd
  • • Eli Lilly and Company
  • • AstraZeneca
  • • Bayer AG
  • • Juno Therapeutics
  • • Allogene Therapeutics
  • • Regen BioPharma
  • • OncoSec Medical Incorporated
  • • Precision BioSciences
  • • Bellicum
  • • GlaxoSmithKline plc
  • • Middle East Gene Therapy Company
  • • DEVA
  • • Biotchpharma
  • • Gene Vector Technologies
  • • BrainStorm Cell Therapeutics
  • • Pluristem
  • • Sanofi
  • • Adcock Ingram

    1. Cell And Gene Therapy Market Executive Summary

    2. Table of Contents

    3. List of Figures

    4. List of Tables

    5. Report Structure

    6. Introduction

    6.1. Segmentation By Geography

    6.2. Segmentation By Product

    6.3. Segmentation By Application

    7. Cell And Gene Therapy Market Characteristics

    7.1. Segmentation By Product

    7.1.1.Cell Therapy

    7.1.2.Gene Therapy

    7.2. Segmentation By Application

    7.2.1.Oncology

    7.2.2.Neurological Disorders

    7.2.3.Others

    8. Cell And Gene Therapy Market Trends And Strategies

    8.1. Chimeric Antigen Receptor (CAR) T-Cell Therapy

    8.2. Global Research Initiatives And Funding

    8.3. Integration Of Advanced Technologies In Cell And Gene Therapies

    8.4. Rising Focus On Gene Editing

    8.5. Increasing Partnerships And Acquisitions For Promoting Cell And Gene Therapies

    8.6. Increasing Number Of Pipeline Studies And Drug Development

    8.7. Growing Investments and Manufacturing Facility Expansion

    9. Impact Of COVID-19 On The Cell And Gene Therapy Market

    9.1. Introduction

    9.2. Impact On Manufacturing And Commercial Operations

    9.3. COVID-19 Impact On Treatment

    9.4. Drug Therapies

    9.5. Conclusion

    10. Global Cell And Gene Therapy Market Size And Growth

    10.1. Market Size

    10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

    10.2.1. Drivers Of The Market 2015 – 2020

    10.2.2. Restraints On The Market 2015 – 2020

    10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    10.3.1. Drivers Of The Market 2020 – 2025

    10.3.2. Restraints On The Market 2020 – 2025

    11. Global Cell And Gene Therapy Market Segmentation

    11.1. Global Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    11.1.1. Gene Therapy

    11.1.2. Cell Therapy

    11.2. Global Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    11.2.1. Oncology

    11.2.2. Neurological Disorders

    11.2.3. Others

    12. Cell And Gene Therapy Market, Regional And Country Analysis

    12.1. Global Cell And Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    12.2. Global Cell And Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13. Asia-Pacific Cell And Gene Therapy Market

    13.1. Asia-Pacific Cell And Gene Therapy Market Overview

    13.1.1. Region Information

    13.1.2. Impact of COVID-19

    13.1.3. Market Information

    13.1.4. Background Information

    13.1.5. Government Initiatives

    13.1.6. Regulations

    13.1.7. Regulatory Bodies

    13.1.8. Major Associations

    13.1.9. Taxes Levied

    13.1.10. Corporate Tax Structure

    13.1.11. Investments

    13.1.12. Major Companies

    13.2. Asia-Pacific Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.3. Asia-Pacific Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.4. Asia-Pacific Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.5. Asia-Pacific Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.6. Asia-Pacific Cell And Gene Therapy Market: Country Analysis

    13.7. China Cell And Gene Therapy Market

    13.8. China Cell And Gene Therapy Market Overview

    13.8.1. Country Information

    13.8.2. Impact of COVID-19

    13.8.3. Market Information

    13.8.4. Background Information

    13.8.5. Government Initiatives

    13.8.6. Regulations

    13.8.7. Regulatory Bodies

    13.8.8. Major Associations

    13.8.9. Taxes Levied

    13.8.10. Corporate Tax Structure

    13.8.11. Investments

    13.8.12. Major Companies

    13.9. China Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.10. China Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.11. China Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.12. China Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.13. India Cell And Gene Therapy Market

    13.14. India Cell And Gene Therapy Market Overview

    13.14.1. Country Information

    13.14.2. Impact of COVID-19

    13.14.3. Market Information

    13.14.4. Background Information

    13.14.5. Government Initiatives

    13.14.6. Regulations

    13.14.7. Regulatory Bodies

    13.14.8. Major Associations

    13.14.9. Tax Levied

    13.14.10.   Corporate Tax Structure

    13.14.11.   Investments

    13.14.12.   Major Companies

    13.15. India Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.16. India Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.17. India Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.18. India Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.19. Japan Cell And Gene Therapy Market

    13.20. Japan Cell And Gene Therapy Market Overview

    13.20.1. Country Information

    13.20.2. Impact of COVID-19

    13.20.3. Market Information

    13.20.4. Background Information

    13.20.5. Government Initiatives

    13.20.6. Regulations

    13.20.7. Regulatory Bodies

    13.20.8. Major Associations

    13.20.9. Tax Levied

    13.20.10.   Corporate Tax Structure

    13.20.11.   Investments

    13.20.12.   Major Companies

    13.21. Japan Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.22. Japan Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.23. Japan Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.24. Japan Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.25. Australia Cell And Gene Therapy Market

    13.26. Australia Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.27. Australia Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.28. Australia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.29. Australia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.30. Indonesia Cell And Gene Therapy Market

    13.31. Indonesia Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.32. Indonesia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.33. Indonesia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.34. South Korea Cell And Gene Therapy Market

    13.35. South Korea Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.36. South Korea Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.37. South Korea Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.38. South Korea Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14. Western Europe Cell And Gene Therapy Market

    14.1. Western Europe Cell And Gene Therapy Market Overview

    14.1.1. Region Information

    14.1.2. Impact Of COVID-19

    14.1.3. Market Information

    14.1.4. Background Information

    14.1.5. Government Initiatives

    14.1.6. Regulations

    14.1.7. Regulatory Bodies

    14.1.8. Major Associations

    14.1.9. Taxes Levied

    14.1.10. Corporate Tax Structure

    14.1.11. Investments

    14.1.12. Major Companies

    14.2. Western Europe Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.3. Western Europe Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    14.4. Western Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.5. Western Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.6. Western Europe Cell And Gene Therapy Market: Country Analysis

    14.7. UK Cell And Gene Therapy Market

    14.8. UK Cell And Gene Therapy Market Overview

    14.8.1. Country Information

    14.8.2. Impact Of COVID-19

    14.8.3. Market Information

    14.8.4. Background Information

    14.8.5. Government Initiatives

    14.8.6. Regulations

    14.8.7. Regulatory Bodies

    14.8.8. Major Associations

    14.8.9. Taxes Levied

    14.8.10. Corporate Tax Structure

    14.8.11. Investments

    14.8.12. Major Companies

    14.9. UK Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.10. UK Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    14.11. UK Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.12. UK Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.13. Germany Cell And Gene Therapy Market

    14.14. Germany Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.15. Germany Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    14.16. Germany Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.17. Germany Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.18. France Cell And Gene Therapy Market

    14.19. France Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.20. France Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    14.21. France Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.22. France Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15. Eastern Europe Cell And Gene Therapy Market

    15.1. Eastern Europe Cell And Gene Therapy Market Overview

    15.1.1. Region Information

    15.1.2. Impact Of COVID-19

    15.1.3. Market Information

    15.1.4. Background Information

    15.1.5. Government Initiatives

    15.1.6. Regulations

    15.1.7. Regulatory Bodies

    15.1.8. Major Associations

    15.1.9. Taxes Levied

    15.1.10. Corporate Tax Structure

    15.1.11. Investments

    15.1.12. Major Companies

    15.2. Eastern Europe Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    15.3. Eastern Europe Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    15.4. Eastern Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.5. Eastern Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.6. Eastern Europe Cell And Gene Therapy Market: Country Analysis

    15.7. Russia Cell And Gene Therapy Market

    15.8. Russia Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    15.9. Russia Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    15.10. Russia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.11. Russia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16. North America Cell And Gene Therapy Market

    16.1. North America Cell And Gene Therapy Market Overview

    16.1.1. Region Information

    16.1.2. COVID-19 Impact

    16.1.3. Market Information

    16.1.4. Background Information

    16.1.5. Regulations

    16.1.6. Regulatory Bodies

    16.1.7. Major Associations

    16.1.8. Taxes Levied

    16.1.9. Corporate Tax Structure

    16.1.10. Investments

    16.1.11. Major Companies

    16.2. North America Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    16.3. North America Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    16.4. North America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.5. North America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.6. North America Cell And Gene Therapy Market: Country Analysis

    16.7. USA Cell And Gene Therapy Market

    16.8. USA Cell And Gene Therapy Market Overview

    16.8.1. Country Information

    16.8.2. COVID-19 Impact

    16.8.3. Market Information

    16.8.4. Background Information

    16.8.5. Government Initiatives

    16.8.6. Regulations

    16.8.7. Regulatory Bodies

    16.8.8. Major Associations

    16.8.9. Taxes Levied

    16.8.10. Corporate Tax Structure

    16.8.11. Investments

    16.8.12. Major Companies

    16.9. USA Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    16.10. USA Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    16.11. USA Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.12. USA Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17. South America Cell And Gene Therapy Market

    17.1. South America Cell And Gene Therapy Market Overview

    17.1.1. Region Information

    17.1.2. COVID-19 Impact

    17.1.3. Market Information

    17.1.4. Background Information

    17.1.5. Government Initiatives

    17.1.6. Regulations

    17.1.7. Regulatory Bodies

    17.1.8. Major Associations

    17.1.9. Taxes Levied

    17.1.10. Corporate Tax Structure

    17.1.11. Investments

    17.1.12. Major Companies

    17.2. South America Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    17.3. South America Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    17.4. South America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.5. South America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.6. South America Cell And Gene Therapy Market: Country Analysis

    17.7. Brazil Cell And Gene Therapy Market

    17.8. Brazil Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    17.9. Brazil Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    17.10. Brazil Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.11. Brazil Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    18. Middle East Cell And Gene Therapy Market

    18.1. Middle East Cell And Gene Therapy Market Overview

    18.1.1. Region Information

    18.1.2. COVID-19 Impact

    18.1.3. Market Information

    18.1.4. Background Information

    18.1.5. Government Initiatives

    18.1.6. Regulations

    18.1.7. Regulatory Bodies

    18.1.8. Major Associations

    18.1.9. Taxes levied

    18.1.10. Corporate Tax Structure

    18.1.11. Investments

    18.1.12. Major Companies

    18.2. Middle East Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    18.3. Middle East Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    18.4. Middle East Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    18.5. Middle East Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19. Africa Cell And Gene Therapy Market

    19.1. Africa Cell And Gene Therapy Market Overview

    19.1.1. Regional Information

    19.1.2. COVID-19 Impact

    19.1.3. Background Information

    19.1.4. Government Initiatives

    19.1.5. Regulations

    19.1.6. Regulatory Bodies

    19.1.7. Associations

    19.1.8. Taxes levied

    19.1.9. Corporate Tax Structure

    19.1.10. Investments

    19.1.11. Major Companies

    19.2. Africa Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.3. Africa Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19.4. Africa Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    20. Global Cell And Gene Therapy Market Competitive Landscape

    20.1. Company Profiles

    20.2. Biogen Inc.

    20.2.1. Company Overview

    20.2.2. Products And Services

    20.2.3. Business Strategy

    20.2.4. Financial Overview

    20.3. Novartis AG

    20.3.1. Company Overview

    20.3.2. Products And Services

    20.3.3. Business Strategy

    20.3.4. Financial Overview

    20.4. Gilead Sciences, Inc.

    20.4.1. Company Overview

    20.4.2. Products And Services

    20.4.3. Business Strategy

    20.4.4. Financial Overview

    20.5. Ionis Pharmaceuticals, Inc.

    20.5.1. Company Overview

    20.5.2. Products And Services

    20.5.3. Business Strategy

    20.5.4. Financial Overview

    20.6. Alnylam Pharmaceuticals, Inc.

    20.6.1. Company Overview

    20.6.2. Products And Services

    20.6.3. Business Strategy

    20.6.4. Financial Overview

    21. Key Mergers And Acquisitions In The Cell And Gene Therapy Market

    21.1. Thermo Fisher Scientific Acquired Viral Vector Business From Novasep for $875.76 million

    21.2. Astellas Acquired Audentes Therapeutics for $3 billion

    21.3. Roche Acquired Spark Therapeutics Incorporated for $4.8 billion

    21.4. Vertex Acquired Semma Therapeutics for $950 million

    21.5. Bayer Acquired BlueRock Therapeutics for $1 billion

    21.6. Biogen Acquired Nightstar Therapeutics for $800 million

    21.7. Catalent Acquired Paragon Bioservices Incorporated for $1.2 billion

    21.8. Novartis Acquired AveXis for $8.7 billion

    22. Cell And Gene Therapy Market Opportunities And Strategies

    22.1. Global Cell And Gene Therapy Market In 2025 – Countries Offering Most New Opportunities

    22.2. Global Cell And Gene Therapy Market In 2025 – Segments Offering Most New Opportunities

    22.3. Global Cell And Gene Therapy Market In 2025 – Growth Strategies

    22.3.1. Market Trend Based Strategies

    22.3.2. Competitor Strategies

    23. Cell And Gene Therapy Market, Conclusions And Recommendations

    23.1. Conclusions

    23.2. Recommendations

    23.2.1. Product

    23.2.2. Price

    23.2.3. Place

    23.2.4. Promotion

    23.2.5. People

    24. Appendix

    24.1. Market Data Sources

    24.2. Research Methodology

    24.3. Currencies

    24.4. Research Inquiries

    24.5. The Business Research Company

    24.6. Copyright and Disclaimer

List Of Tables

    Table 1: Global Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 2: Global Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 3: Global Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 4: Global Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 5: Global Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 6: Global Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 7: Global Cell And Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 8: Global Cell And Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 9: Global Cell And Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 10: Global Cell And Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 11: Asia-Pacific Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 12: Asia Pacific GDP Per Capita, 2015-2020, $
  • Table 13: Asia Pacific Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 14: Asia-Pacific Cell and Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 15: Asia-Pacific Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 16: Asia-Pacific Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 17: Asia-Pacific Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 18: Asia-Pacific Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 19: Asia-Pacific Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 20: Asia-Pacific Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 21: China Cell And Gene Therapy Market, Healthcare Expenditure, 2015-2019, $ Billion
  • Table 22: China GDP Per Capita, 2015-2020, $
  • Table 23: China Cell And Gene Therapy Market, Population By Age Group, 2015-2023, Thousands
  • Table 24: China Cell And Gene Therapy Market, Biologics Market Size, 2015-2025, $ Billion
  • Table 25: China Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 26: China Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 27: China Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 28: China Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 29: China Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 30: China Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 31: India Cell And Gene Therapy Market, Healthcare Expenditure, 2015-2019, $ Billion
  • Table 32: India GDP Per Capita, 2015-2020, $
  • Table 33: India Cell And Gene Therapy Market, Population By Age Group, 2015-2023, Thousands
  • Table 34: India Cell And Gene Therapy Market, Biologics Market Size, 2015-2025, $ Billion
  • Table 35: India Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 36: India Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 37: India Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 38: India Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 39: India Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 40: India Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 41: Japan Cell And Gene Therapy Market, Healthcare Expenditure, 2015-2019, $ Billion
  • Table 42: Japan GDP Per Capita, 2015-2020, $
  • Table 43: Japan Cell And Gene Therapy Market, Population By Age Group, 2015-2023, Thousands
  • Table 44: Japan Cell And Gene Therapy Market, Biologics Market Size, 2015-2025, $ Billion
  • Table 45: Japan Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 46: Japan Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 47: Japan Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 48: Japan Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 49: Japan Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 50: Japan Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 51: Australia Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 52: Australia Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 53: Australia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 54: Australia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 55: Australia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 56: Australia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 57: Indonesia Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 58: Indonesia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 59: Indonesia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 60: Indonesia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 61: Indonesia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 62: South Korea Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 63: South Korea Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 64: South Korea Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 65: South Korea Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 66: South Korea Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 67: South Korea Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 68: Western Europe Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 69: Western Europe GDP Per Capita, 2015-2020, $
  • Table 70: Western Europe Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 71: Western Europe Cell And Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 72: Western Europe Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 73: Western Europe Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 74: Western Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 75: Western Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 76: Western Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 77: Western Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 78: UK Cell And Gene Therapy Market, Healthcare Expenditure, 2015-2019, $ Billion
  • Table 79: UK GDP Per Capita, 2015-2020, $
  • Table 80: UK Cell And Gene Therapy Market, Population By Age Group, 2015-2023, Thousands
  • Table 81: UK Cell And Gene Therapy Market, Biologics Market Size, 2015-2025, $ Billion
  • Table 82: UK Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 83: UK Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 84: UK Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 85: UK Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 86: UK Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 87: UK Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 88: Germany Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 89: Germany Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 90: Germany Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 91: Germany Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 92: Germany Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 93: Germany Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 94: France Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 95: France Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 96: France Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 97: France Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 98: France Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 99: France Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 100: Eastern Europe Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 101: Eastern Europe GDP Per Capita, 2015-2020, $
  • Table 102: Eastern Europe Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 103: Eastern Europe Cell And Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 104: Eastern Europe Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 105: Eastern Europe Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 106: Eastern Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 107: Eastern Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 108: Eastern Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 109: Eastern Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 110: Russia Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 111: Russia Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 112: Russia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 113: Russia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 114: Russia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 115: Russia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 116: North America Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 117: North America GDP Per Capita, 2015-2020, $
  • Table 118: North America Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 119: North America Cell And Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 120: North America Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 121: North America Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 122: North America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 123: North America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 124: North America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 125: North America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 126: USA Cell And Gene Therapy Market, Healthcare Expenditure, 2015-2019, $ Billion
  • Table 127: USA GDP Per Capita, 2015-2020, $
  • Table 128: USA Cell And Gene Therapy Market, Population By Age Group, 2015-2023, Thousands
  • Table 129: USA Cell And Gene Therapy Market, Biologics Market Size, 2015-2025, $ Billion
  • Table 130: USA Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 131: USA Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 132: USA Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 133: USA Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 134: USA Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 135: USA Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 136: South America Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 137: South America GDP Per Capita, 2015-2020, $
  • Table 138: South America Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 139: South America Cell And Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 140: South America Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 141: South America Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 142: South America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 143: South America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 144: South America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 145: South America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 146: Brazil Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 147: Brazil Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 148: Brazil Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 149: Brazil Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 150: Brazil Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 151: Brazil Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 152: Middle East Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 153: Middle East GDP Per Capita, 2015-2020, $
  • Table 154: Middle East Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 155: Middle East Cell And Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 156: Middle East Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Table 157: Middle East Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 158: Middle East Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 159: Middle East Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 160: Middle East Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 161: Middle East Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 162: Africa Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
  • Table 163: Africa GDP Per Capita, 2015-2020, $
  • Table 164: Africa Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 165: Africa Cell And Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
  • Table 166: Africa Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 167: Africa Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 168: Africa Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 169: Africa Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 170: Africa Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 171: Global Cell And Gene Therapy Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 172: Biogen Inc. – Financial Performance, 2015 – 2019, $ Million
  • Table 173: Novartis AG – Financial Performance, 2016 - 2020, $ Billion
  • Table 174: Gilead Sciences, Inc. –  Financial Performance, 2015 – 2019, $ Billion
  • Table 175: Ionis Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million
  • Table 176: Alnylam Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million
  • Table 177: Global Cell And Gene Therapy Market Size Gain ($ Million), 2020 – 2025, By Country
  • Table 178: Global Cell And Gene Therapy Market Size Gain ($ Million), Segmentation By Product, 2020 – 2025
  • Table 179: Global Cell And Gene Therapy Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025
  • Table 180: Cell And Gene Therapy - Market Data Sources

List Of Figures

    Figure 1: Global Cell And Gene Therapy Market Segmentation By Product
  • Figure 2: Global Cell And Gene Therapy Market Segmentation By Application
  • Figure 3: Global Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 4: Global Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 5: Global Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 6: Global Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 7: Global Cell And Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 8: Global Cell And Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 9: Asia-Pacific Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 10: Asia-Pacific Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 11: Asia-Pacific Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 12: Asia-Pacific Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 13: China Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 14: China Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 15: China Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 16: China Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 17: India Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 18: India Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 19: India Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 20: India Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 21: Japan Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 22: Japan Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 23: Japan Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 24: Japan Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 25: Australia Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 26: Australia Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 27: Australia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 28: Australia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 29: Indonesia Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 30: Indonesia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 31: Indonesia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 32: South Korea Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 33: South Korea Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 34: South Korea Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 35: South Korea Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 36: Western Europe Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 37: Western Europe Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 38: Western Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 39: Western Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 40: UK Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 41: UK Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 42: UK Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 43: UK Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 44: Germany Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 45: Germany Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 46: Germany Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 47: Germany Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 48: France Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 49: France Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 50: France Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 51: France Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 52: Eastern Europe Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 53: Eastern Europe Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 54: Eastern Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 55: Eastern Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 56: Russia Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 57: Russia Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 58: Russia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 59: Russia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 60: North America Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 61: North America Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 62: North America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 63: North America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 64: USA Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 65: USA Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 66: USA Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 67: USA Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 68: South America Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 69: South America Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 70: South America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 71: South America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 72: Brazil Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 73: Brazil Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 74: Brazil Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 75: Brazil Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 76: Middle East Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
  • Figure 77: Middle East Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 78: Middle East Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 79: Middle East Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 80: Africa Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 81: Africa Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 82: Africa Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 83: Global Cell And Gene Therapy Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 84: Biogen Inc. – Financial Performance, 2015 – 2019, $ Million
  • Figure 85: Novartis AG – Financial Performance, 2016 - 2020, $ Billion
  • Figure 86: Gilead Sciences, Inc. – Financial Performance, 2015 – 2019, $ Billion
  • Figure 87: Ionis Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million
  • Figure 88: Alnylam Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million
Global Lung Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Kidney Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Interleukin Inhibitors Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Immunosuppressants Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Inhalation Sedatives Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Insulin Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cancer Monoclonal Antibodies Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Clinical Nutrition Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Dry Eye Medication Market - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous and Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Pharmaceutical Drugs Market - By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Musculoskeletal Drugs Market Global Briefing 2018
View Report
Respiratory Drugs Market Global Briefing 2018
View Report
Antisense And RNAi Therapeutics Market- By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous injections, Intra Dermal injunctions, Other delivery methods), By Indication (Oncology, Cardiovascular device, Respiratory disorders, Neurological disorders, Infectious disease, Other diseases), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)